SCHEMBL13367175

SCHEMBL13367175

CC[C@]1(C)CO1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2708067 1.00
SCHEMBL78830 1.00
SCHEMBL8513928 0.97 KDM4E (0.33)
SCHEMBL16248006 0.97 KDM4E (0.33)
Phosphine SCHEMBL28056004 0.97
Phosphoric Acid SCHEMBL4953743 0.84 KDM4E (0.32)
Phosphoric Acid SCHEMBL4948011 0.84 KDM4E (0.32)
SCHEMBL10624955 0.80
SCHEMBL9975648 0.78
SCHEMBL14583499 0.76 CHRM2 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117986241-A Biphenyl derivative, pharmaceutical composition and application thereof 武汉睿健医药科技有限公司 2024-05-07 CN disclosed
US-20160058874-A1 CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY CERULEAN PHARMA INC. (US) 2016-03-03 US disclosed
US-20150284362-A1 CARBAZOLE-CONTAINING AMIDES, CARBAMATES, AND UREAS AS CRYPTOCHROME MODULATORS Synchronicity Pharma, Inc. 2015-10-08 US disclosed
US-20150005230-A1 CYCLODEXTRIN-BASED POLYMERS FOR THERAPEUTIC DELIVERY CERULEAN PHARMA INC. (US) 2015-01-01 US disclosed
US-20100112658-A1 Transformed Saccharomyces cerevisiae Engineered for Xylose Utilization LIFESENSORS, INC. 2010-05-06 US disclosed